SHORT MINI-FUTURE - BIOGEN IDEC | Delayed Deutsche Boerse AG 13:46:51 2024-05-15 EDT | ||
| 20.93 EUR | -5.08% |
|
| Current month | -4.50% | ||
| 1 month | -10.73% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-05-15 | 20.93 | -5.08% |
| 24-05-14 | 22.05 | -0.41% |
| 24-05-13 | 22.14 | -0.90% |
| 24-05-10 | 22.34 | -0.31% |
| 24-05-09 | 22.41 | -0.66% |
Delayed Quote Deutsche Boerse AG
Last update May 15, 2024 at 01:46 pm
More quotesStatic data
| Product type | Knock-Out mit Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BIOGEN INC. |
| Issuer | 
Vontobel
|
| WKN | VQ8H9K |
| ISIN | DE000VQ8H9K1 |
| Date issued | 2021-06-09 |
| Strike | 462.5 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 6.81 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 26.91 € |
|---|---|
| Lowest since issue | 3.82 € |
| Spread | 0.03 € |
| Spread % | 0.14% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
226.9
USD
Average target price
285.9
USD
Spread / Average Target
+26.02%
- Stock Market
- Certificates
- Certificat
